No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Tuesday's After-Market Session
Iridex Shares Fall on Preliminary 1Q Sales Estimate
Iridex Expects 1Q Revenue to Be Flat to Slightly Higher
IRIDEX | 8-K: Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
Iridex: Delivered Top-Line Rev Increases Vs Prior Yr in Each of Last Two Quarters, Even While Significantly Reducing Operating Expenses >IRIX
Iridex: Exposed to External Factors Like Changes in Tariff Policies, Remain Capable of Achieving Breakeven or Better Performance at Historical Rev Levels >IRIX